23andMe independent directors quit board over unsatisfactory buyout plan from CEO

Sept 17 (Reuters) - The independent directors of genetic testing firm 23andMe (ME.O) said on Tuesday they have resigned from the company's board after not receiving a satisfactory take-private offer from CEO Anne Wojcicki. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share , in July. "After months of work, we have yet to receive from you a fully financed, fully diligenced, actionable proposal that is in the...